RxDoctor Payments Data

Anne Malcolm

Psychiatric/Mental Health · Ogdensburg, NYNPI 1922644624

Payments from drug & device makers

$1,227in general payments, 2019–2025

Across 57 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$438
  • Alkermes, Inc.$243
  • Otsuka America Pharmaceutical, Inc.$224
  • E.r. Squibb & Sons, L.L.C.$100
  • Johnson & Johnson$62
  • Teva Pharmaceuticals USA, Inc.$48
  • plus $112 from 4 others

What the payments were for

  • Food & beverage$1,20098%
  • Education$272%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,227 in reported general payments places this provider in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Medicare billing

Part B allowed, 2024
$8,535
Medicare patients
29
Services billed
99

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$89,183
Abilify MaintenaAripiprazole27$72,223
Invega SustennaPaliperidone Palmitate22$58,246
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl42$7,005
VyvanseLisdexamfetamine Dimesylate11$3,813
Aripiprazole76$2,188
Buprenorphine Hcl64$2,123
Fluphenazine Hcl33$2,082
Divalproex Sodium ErDivalproex Sodium19$1,178
Clozapine18$1,060
Olanzapine97$996
Quetiapine Fumarate57$893
Bupropion XlBupropion Hcl52$788
Gabapentin81$745
Mirtazapine45$703

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$224$72,22327 claims
Johnson & JohnsonInvega Sustenna$62$58,24622 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Ogdensburg

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →